PATH announces leader for Reproductive Health Program

November 1, 2016 by PATH

Martha Brady to lead PATH’s work in reproductive health

Martha Brady, MS, will join PATH as the new director of our Reproductive Health Program, beginning November 1, 2016. Based in our Washington, DC, office, she will lead our work to improve sexual and reproductive health by enhancing commitment and capacity to implement appropriate and effective interventions at scale. Her technical knowledge, experience, and track record in reproductive health will ensure continued robust and pioneering work in this area, and they will expand PATH's work at this critical time in global health.

A global leader in improving the health of girls and young women

Ms. Brady has more than 25 years of experience as a program leader, researcher, technical advisor, and evaluator of health and development programs. She holds a master of science in nutrition and public health from Columbia University. Throughout her career, she has focused on sexual and reproductive health and rights, and on issues of poverty, gender, and youth. She has worked along many aspects of the value chain from product development, access and introduction, and health system integration across a range of reproductive health products and delivery platforms. She brings a social science research perspective and gendered analysis to this work.

Most recently, Ms. Brady was senior associate at the Population Council, where her work focused on improving the health and well-being of girls and young women. She codirected a global implementation science program aimed at building the evidence base on cross-sector programming for adolescent girls. She led a recent evidence review and is coauthor of Investing When it Counts: Reviewing the Evidence and Charting a Course of Research and Action for Young Adolescents.

During her career at the Population Council, Ms. Brady served in several roles, including as director of the Expanding Contraceptive Choice Program, aimed at facilitating access and uptake of contraceptive products in public- and private-sector markets. She began her work on early clinical trials of the first contraceptive implant. More recently, she led the Population Council's access-related work on multipurpose prevention technologies, microbicides, and antiretroviral-based prevention for women. She is a valued member of several interagency working groups, consortia, and coalitions working in the global health arena.

Posted November 1, 2016.